OR WAIT null SECS
October 26, 2021
mRNA jab maker plans to initially produce 50 million Covid vaccine doses per year
October 25, 2021
Deal provides ten23 with drug product development, biologic manufacturing experience
October 21, 2021
Agreement prioritizes ways to better distinguish biological manufacturing processes
October 20, 2021
As companies seek interoperability across their organizations, a joint approach to medical information and local pharmacovigilance may deliver future benefits
Italian facilities will supply EU with up to 85 million doses of Covid jab
October 19, 2021
Biologics manufacturer to construct new C> facility to support expansion
October 18, 2021
Facility meets cGMP standards for radiopharmaceutical production
CDTMO’s fourth site further expands its support of cell therapy delivery and access
October 15, 2021
Second NJ location will complement global HQ, offer plasmid DNA and AAV production services
October 13, 2021
Second Carlsbad location expected to double CDMO’s production capacity